WHO global benchmarking tool plus rev. VI+ ver. 1 - Vigilance (VL)
Indicators and fact sheets
1 November 2019
| Technical document

Overview
Medical products vigilance, defined as the science and activities relating to the detection, assessment, understanding and prevention of adverse effects or any other medical product‐related problems, is extremely important for guaranteeing that safe and effective medical products of high quality are used within the country. Vigilance activities should be established in the countries based on a risk management approach.
WHO Team
Regulatory Systems Strengthening MHP (RSS)
Number of pages
56